http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-036335-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-70
filingDate 2002-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_966e1a97b7e23213202343d0fd3ece3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e8365bb02530ec92df3a802207d3a97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9de2f92a9c6e08cfa6910a9271a3013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b61fa4b6ace9ceddf36ca86ac471b2ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8199a4c9db49e18b2b8d2fbbe62b8b08
publicationDate 2004-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-036335-A1
titleOfInvention SUBSTITUTED COMPOUNDS OF 1-PHENETHYLIPIPERIDINE, PROCEDURE TO PREPARE IT, MEDICINAL PRODUCT AND ITS USE TO PREPARE A MEDICINAL PRODUCT
abstract Substituted compounds of 1-phenethylpiperidine of the general formula (1), where X is a methylene- (CH2) - or carbonyl- (C = O) group, preferably, is a methylene- (CH2) - group; R1 is an aryl or heteroaryl radical, if at least one monosubstituted, preferably an aryl radical, if at least one, monosubstituted; R2 is H, COR5, SO2R5, a branched or unbranched aliphatic C1-10 radical, saturated, optionally at least monosubstituted, a branched or unbranched aliphatic C2-10 radical, optionally at least monosubstituted, at least monounsaturated, a C3- radical 8 cycloaliphatic optionally at least monosubstituted, saturated or at least monounsaturated, an aryl or heteroaryl radical optionally at least monosubstituted or an aryl or heteroaryl radical optionally at least monosubstituted attached through a C1-3 alkylene group, preferably H, COR5, SO2R5 or a C1-6 alkyl radical, preferably, H or COR5; R3 and R4 are, in each case, H or together they are a union, preferably they are, in each case, H, R5 is a branched or unbranched aliphatic C1-10 radical, saturated, optionally at least monosubstituted, a C2-10 radical branched or unbranched aliphatic, optionally at least monosubstituted, at least monounsaturated, a C3-8 cycloaliphatic radical optionally at least monosubstituted, saturated or at least monounsaturated, an aryl or heteroaryl radical optionally at least monosubstituted or an aryl or heteroaryl radical optionally at least monosubstituted linked through a C1-3 alkylene group preferably a C1-6 alkyl radical or an optionally at least monosubstituted aryl radical, as a free base or the corresponding physiologically acceptable salt and the corresponding racemates, enantiomers and diastereomers. A process is also disclosed for preparing said compounds, the medicament that comprises them and the use thereof for the preparation of medicaments useful for pain control, for the treatment of migraine, diarrhea, urinary incontinence, pruritus, inflammatory reactions, allergic reactions. , dependence on alcohol and / or drugs and / or medications, alcohol and / or drug abuse and / or medications, inflammations or local anesthesia.
priorityDate 2001-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9513

Total number of triples: 33.